Getinge company profile
Company profile
Getinge has 11,847 employees and is headquartered in Gothenburg, Sweden.
Sales reach customers in the Americas, Europe, the Middle East, Africa, and Asia and Pacific, through a network of the company's own sales companies as well as through agents and distributors. The product range covers extracorporeal membrane oxygenation, mechanical ventilation, patient monitoring and drainage systems, along with cardiac and vascular surgery equipment, peripheral stenting, and anesthesia and operating room integration. Its sterilization and reprocessing offering includes cleaning, disinfection, endoscope reprocessing and sterile supply management, while its Life Science activities supply bioreactor preparation, bioprocess development, biocontainment and vivarium solutions.
In the fiscal year ended December 2025, revenue amounted to SEK 35.0 billion, up 0.6% from the previous year, and net income reached SEK 2.3 billion. The group employed 11,847 people. The company was founded in 1904 and has its headquarters in Gothenburg, Sweden.
Company facts
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Sweden
- Headquarters
- Lindholmspiren 7A, 417 56, Gothenburg
- Employees
- 11,847
- Chief executive
- Mattias Perjos
- Founded
- 1904
- Fiscal year
- January - December
- Listing
- GETI.B · Nasdaq Stockholm
- Currency
- SEK
- ISIN
- SE0000202624
- Website
- getinge.com
Getinge and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| GetingeGETI.B | Sweden | $7.39B | 11,847 | 14.3% | 26.6 |
| SectraSECT.B | Sweden | $6.24B | 1,403 | 20.6% | 105.8 |
| DemantDEMANT | Denmark | $10.7B | 26,616 | 17.2% | 30.1 |
| Smith & NephewSN. | United Kingdom | $12.57B | 17,000 | 14.2% | 20.8 |
| AmbuAMBU.B | Denmark | $3.4B | 4,664 | 13.2% | 36.7 |
| Sonova HoldingSOON | Switzerland | $20.67B | 18,837 | 20.6% | 28.9 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
